Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747461 · ClinicalTrials.gov registry record · Phase 4
Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")
A Phase 4 study, sponsored by CSA Medical.
- Terminated
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT00747461 is a Phase 4 study that was terminated before completion, run by CSA Medical. The registered enrollment target is 5 participants.
The verdict
NCT00747461, a Phase 4 study, was terminated before completion, sponsored by CSA Medical.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchoscopy (FFB)
Interventions
- DEVICE CryoSpray Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00747461
The ClinicalTrials.gov registry entry for NCT00747461 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CSA Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CryoSpray Ablation is the first listed.
NCT00747461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00747461 about?
NCT00747461 is a clinical study titled "Interventional Cryotherapy for the Eradication of Benign Airway Disease ("ICE the BAD")". The purpose of this study is to evaluate the safety, effectiveness, and side effects of the CryoSpray AblationTM System (CryoSpray AblationTM, "CSA" or "cryospray therapy") to treat benign airway disease in the lung using liquid nitrogen sprayed through a catheter via flexible fiber optic bronchosco...
What is the current status of trial NCT00747461?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2008-10. Estimated completion is 2011-03.
What interventions are being tested in trial NCT00747461?
The interventions under investigation include: CryoSpray Ablation (DEVICE).
Who is sponsoring clinical trial NCT00747461?
This trial is sponsored by CSA Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.